anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

196,921-196,980 of 319,975

filter-aware
02
HSBC | Investor Day Presentation Deck | 13 slidesHSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · Problem1 hit
03
Includes a pyramid diagram for client segmentation and a bar chart for competitive benchmarking.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · Problem1 hit
04
GPS likely stands for Global Payments Solutions. Slide uses a mix of donut, bar, and stacked bar charts to illustrate growth and contribution.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · ProblemLoop · Benchmark Gap1 hit
05
Includes footnote regarding lending activities.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · ProblemLoop · Benchmark Gap1 hit
06
The slide uses a 3-column layout to map ambitions to actions and benefits.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
07
Slide 6 of a presentation, likely HSBC investor deck.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
08
HSBC | Investor Day Presentation Deck | 13 slidesHSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
09
Includes an organizational chart snippet showing reporting lines to Group CEO and other CEOs.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
10
HSBC | Investor Day Presentation Deck | 13 slidesHSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
11
HSBC | Investor Day Presentation Deck | 13 slidesHSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
12
HSBC | Investor Day Presentation Deck | 13 slidesHSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
13
This is a standard corporate branding slide, likely used as a title or transition page.HSBC | Investor Day Presentation Deck | 13 slides · HSBC
Conference presentation Investor relations 1 hit
01
Slide 1
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
02
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
03
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
04
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Problem Identification1 hit
05
The slide uses color coding to distinguish between Oncology (dark blue) and Immunology-Inflammation (orange) programs.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
06
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
07
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
08
Includes a table of prevalence/incidence for specific indications and a biological pathway diagram.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
09
The slide uses a dual-panel layout: left shows tumor volume reduction over time with weekly dosing; right shows PK/PD relationship highlighting the 48-hour window of STAT3 knockdown.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
10
The slide uses a process flow diagram to illustrate the transition from dose escalation to expansion cohorts.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
11
Clinical trial safety data presentation.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
12
PK parameters include Cmax, AUC, Vd, CL, and t1/2 with associated coefficients of variation.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
13
The slide validates clinical findings against preclinical models.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · AgitationLoop · Before After1 hit
14
DL = Dose Level; DLT = Dose Limiting Toxicity; SAE = Serious Adverse Event.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · AgitationLoop · Before After1 hit
15
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Agitation1 hit
16
Includes a biological pathway diagram showing signaling cascades and a table of prevalence/incidence for three specific lymphoma types.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
17
Shows efficacy data (tumor volume) alongside PK/PD mechanism data (degradation over time).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
18
The slide uses a process flow diagram to illustrate dose escalation steps (0.16 to DLX) and a table for study objectives.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
19
The slide highlights the absence of dose-limiting toxicities (DLTs) and serious adverse events (SAEs) in the initial dose cohorts.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
20
The chart shows a log-scale y-axis for plasma concentration. The table summarizes Cmax, AUCinf, Vd, CL, and t1/2 for both dose levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
21
The slide uses line charts for longitudinal PBMC data and a bar chart for tumor knockdown data, supported by summary tables.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
22
POM = Proof of Mechanism; PK = Pharmacokinetics; PD = Pharmacodynamics; DL = Dose Level; KD = Knockdown; DLT = Dose-Limiting Toxicity; SAE = Serious Adverse Event.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
23
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
24
The slide uses a biological pathway diagram to contrast the 'scaffolding' and 'kinase' roles of IRAK4, arguing that degradation blocks both, whereas inhibitors only block the kinase role.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
25
Includes mechanism illustration, dose-response curves, and a comparative table of IC50 values.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
26
Includes a mechanism of action diagram, a market data table, and a callout box for competitive limitations.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
27
The slide outlines a multi-part clinical trial (Parts A, B, and C) with specific dosing, randomization, and outcome metrics.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
28
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
29
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
30
The table uses specific clinical metrics (HS-PGA, vIGA-AD, AN count, EASI score) to characterize the study populations.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
31
The table includes sub-categorization of completed treatments by severity levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
32
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
33
Includes three distinct charts: a line chart for PK over time, a scatter plot for PK/PD correlation, and a box plot for IRAK4 levels.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
34
Data represents Part C: 75 mg QD (fed). Error bars represent standard error (SE).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
35
The chart uses a dotted horizontal line to indicate the baseline level of healthy subjects for visual comparison.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
36
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
37
The slide highlights that all reported adverse events were mild (except one severe headache) and all patients recovered.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
38
Data presented as mean change from baseline with 90% CI. n=9 for MAD3 and n=20 for Part C (n=19 for day 14).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
39
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
40
The slide uses a grouped bar chart format to compare efficacy across three cohorts for two different stimulation conditions (LPS and R848).Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Solution1 hit
41
The chart specifically tracks IL-6 levels over 42 days.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
42
The slide uses individual patient IDs on the y-axis and log2 fold change on the x-axis to visualize gene expression changes.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
43
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
44
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
45
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
46
Includes error bars representing standard error of the mean.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
47
Data presented as line charts with error bars representing standard error or confidence intervals.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit
48
The chart tracks 7 patients over time, showing a shift from severe/moderate to mild categories.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · Action1 hit